Develops drugs for periodontitis and oral leukoplakia.
Mar 2025Revenue $5.00K/yrExpenses $2.92M/yr
Fell below break-even Apr 2019
Figures by year
When will Nordicus Partners be profitable again?
Its expenses passed its revenue in Apr 2019. In the 12 months to Mar 2025, revenue was $5.00K and expenses $2.92M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2025 | $5.00K | $2.92M | −$2.92M |
| Mar 2024 | $2.50K | $310K | −$308K |
| Mar 2019 | $3.35K | $2.60K | $751 |
| Mar 2018 | $2.92K | $2.74K | $181 |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.